fda semaglutide decision Decisions Expected: October 2025 - Prime Therapeutics US FDA approves weight loss

GLP-1

Galenicum will handle development and manufacturing

Its important to note that the platform does not offer therapy or comprehensive psychiatric care

A Agncia Nacional de Vigilncia Sanitria (Anvisa) proibiu as injees de tirzepatida das marcas Synedica e TG, que estavam sendo vendidas no Brasil sem registro e so conhecidas como canetas emagrecedoras do Paraguai.

Have you been frustrated that youve tried: Diets Exercise Medications Maybe those things work for a while, but are not working to the degree that youd like

A new study has found that Wegovy, an obesity treatment drug recently launched in South Korea, is also effective for knee arthritis